NCT00955292View on ClinicalTrials.gov

Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas

PHASE1TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

December 31, 2008

Conditions
Advanced Solid TumorsLymphoma
Interventions
DRUG

Quarfloxin

Escalating doses of quarfloxin administered intravenously for 24 hours once weekly for three weeks every four weeks

Trial Locations (2)

Unknown

Scottsdale

San Antonio

Sponsors
All Listed Sponsors
lead

Cylene Pharmaceuticals

INDUSTRY